financetom
Business
financetom
/
Business
/
Vivid Seats Faces Challenges Amid Uncertain Consumer Spending Trends, Rising Competition, BofA Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vivid Seats Faces Challenges Amid Uncertain Consumer Spending Trends, Rising Competition, BofA Says
Mar 13, 2025 8:13 AM

10:55 AM EDT, 03/13/2025 (MT Newswires) -- Vivid Seats' ( SEAT ) growth and margin profile are set to be affected by an uncertain consumer spending environment and rising peer competition within the secondary ticketing market, BofA Securities said in a note Thursday.

The analysts said they noticed a change in management's outlook for live events in 2025, as the industry has experienced negative trends over the last six weeks, compared to initial expectations of double-digit growth. While some of this is due to tough comparisons in Q1, management also mentioned potential consumer weakness in Las Vegas, which raises concerns about growth in H2. The analysts added that Vivid Seats ( SEAT ) may need to increase marketing spending, which could reduce its profit margins, as competition is expected to remain high in 2025.

The analysts said the company's guidance also reflects increased competition, with management providing a wider gross order value range than usual, and the midpoint of earnings before interest, taxes, depreciation, and amortization implying a margin contraction. Management expects to make "additional investments in marketing and technology" to protect Vivid Seats' ( SEAT ) market position and boost volumes. However, it also pointed out that marketing expenses have historically been "uneconomic," a trend expected to continue in 2025.

"The consumer spending environment remains cloudy, and competition within the secondary ticketing market is elevated with peers focused on driving volumes," the analysts said, adding they expect these issues to weigh on the company's growth and margin profile.

BofA Securities downgraded Vivid Seats ( SEAT ) to underperform from buy and cut its price target to $2.60 from $6.25.

Price: 2.80, Change: -0.11, Percent Change: -3.62

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Proxy adviser ISS recommends Pfizer shareholders reject executive compensation proposal
Proxy adviser ISS recommends Pfizer shareholders reject executive compensation proposal
Apr 2, 2025
April 2 (Reuters) - Institutional Shareholder Services has recommended Pfizer ( PFE ) investors reject a proposal on executive compensation due to changes made in the long-term awards for CEO Albert Bourla and other top executives. The proxy adviser said on Wednesday that the changes added about $1 million in additional value for CEO. The modification significantly undermines the at-risk...
Over a third of EM corporations to be 'meaningfully impacted' by tariffs, says JPMorgan
Over a third of EM corporations to be 'meaningfully impacted' by tariffs, says JPMorgan
Apr 2, 2025
LONDON (Reuters) - More than a third of emerging market companies are likely to be meaningfully impacted by U.S. trade tariffs when they hit, analysts at investment bank JPMorgan have estimated. Including the likelihood that Chinese and Mexican firms are hit hard, they estimated that 36% of the more than 750 companies in the bank's closely followed CEMBI EM corporate...
Chinese firms place $16 billion in order for new Nvidia chips, the Information reports
Chinese firms place $16 billion in order for new Nvidia chips, the Information reports
Apr 2, 2025
(Reuters) - Chinese companies including ByteDance, Alibaba Group ( BABA ) and Tencent Holdings ( TCTZF ) have placed at least $16 billion in orders for Nvidia's ( NVDA ) H20 server chips in the first three months of the year, the Information reported on Wednesday, citing two people with direct knowledge of the transactions. (Reporting by Priyanka.G in Bengaluru;...
Proxy adviser ISS recommends Pfizer shareholders reject executive compensation proposal
Proxy adviser ISS recommends Pfizer shareholders reject executive compensation proposal
Apr 2, 2025
(Reuters) -Institutional Shareholder Services has recommended Pfizer ( PFE ) investors reject a proposal on executive compensation due to changes made in the long-term awards for CEO Albert Bourla and other top executives. The proxy adviser said on Wednesday that the changes added about $1 million in additional value for CEO. The modification significantly undermines the at-risk nature of the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved